Categories: News

HonKuwa, with Academician Yoshiki Sawa, Ushering in a New Era of Innovative Drug R & D.

TOKYO, JAPAN – Media OutReach Newswire – 15 October 2024 – HonKuwa Pharmaceutical Co., Ltd. officially announces a strategic partnership with Professor Yoshiki Sawa, a world-renowned expert in the field of regenerative medicine and an academician of the Engineering Academy of Japan. Professor Sawa has been appointed as the honorary chief research scientist of HonKuwa. At the signing ceremony held at InterContinental Osaka, both parties jointly embark on a new chapter in the exploration of innovative drugs.

This cooperation is designed to combine Professor Sawa’s outstanding research in cell biology and regenerative medicine with HonKuwa’s cutting-edge product development capabilities, promoting innovative treatment solutions in the fields of joint and muscle injury repair. Professor Sawa stated, “I have been dedicated to regenerative science research and clinical practice. I look forward to closely integrating the latest technology in this field with HonKuwa’s products and exploring how to better apply scientific and technological achievements in clinical settings to help more patients improve their health. I have full confidence in HonKuwa’s team and expect to work together to transform scientific research results into practical health solutions.”

HonKuwa Pharmaceutical Co., Ltd. was established in 2011 and is focused on the production and trade of health foods, medical products, and medical devices. Adhering to the business philosophy of “quality first, reputation supreme,” it is committed to providing high-quality health products for global users. This cooperation marks an important step forward for HonKuwa in the field of global innovative drug research and development. Both sides will jointly contribute more groundbreaking scientific research results to the medical and health field.

Hashtag: #HonKuwa

https://www.hndashengkeji.com/

The issuer is solely responsible for the content of this announcement.

About HonKuwa Pharmaceutical

Since its establishment, HonKuwa has been consistently dedicated to researching and producing health products with high quality standards, covering areas such as health foods, medical products, and medical devices. The company is committed to promoting the development of global health through continuous innovation and helping more people achieve a better quality of life.

Miscw.com

Recent Posts

Profiting from the crypto boom: Octa broker’s guide to leveraged trading

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 19 December 2024 - With Bitcoin going…

9 minutes ago

Lexus Drives into Its Fifth Year as The Official Automotive Partner of The HSBC Women’s World Championship 2025

SINGAPORE – Media OutReach Newswire - 19 December 2024 - Lexus proudly announces its fifth…

9 minutes ago

CKS Spreads Christmas Cheer at Hope Centre Singapore with CSR Activity

SINGAPORE - Media OutReach Newswire - 19 December 2024 - In the spirit of giving…

9 minutes ago

Osome Reports Over 25% Revenue Growth, Driven by Product and Operational Progress, Sets 2025 Roadmap for Sustainable Growth

Osome’s NPS has nearly tripled q-o-q, reflecting significant improvements in customer satisfaction and loyalty. CAC…

1 hour ago

Osome Reports Over 25% Revenue Growth, Driven by Product Demand and Increased Customer Engagement, Sets 2025 Roadmap for Sustainable Growth

Osome’s NPS has nearly tripled q-o-q, reflecting significant improvements in customer satisfaction and loyalty. CAC…

1 hour ago

Honoring Excellence: The Philippines’ Pioneering Achievements at ACES Awards 2024

BANGKOK, THAILAND - Media OutReach Newswire – 19 December 2024 - At the ACES Awards…

2 hours ago